Skip to main content
SpringerLink
Log in

Photoprotection for Photodermatoses

  • Chapter
  • First Online:
Principles and Practice of Photoprotection

Abstract

This chapter provides a brief overview of the many skin diseases caused by exposure to sunlight, the photodermatoses. The proposed etiology, physical exam findings, preventive care recommendations, and medical therapies unique to each photodermatosis are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Brenner M, Hearing V (2008) The protective role of melanin against UV damage in human skin. Photochem Photobiol 84(3):539–549

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Diffey B, Kochevar I (2007) Basic principles of photobiology. In: Lim H, Honigsmann H, Hawk JL (eds) Photodermatology. Informa Healthcare, New York, pp 15–27

    Google Scholar 

  3. Santoro FA, Lim HW (2011) Update on photodermatoses. Semin Cutan Med Surg 30(4):229–238

    Article  CAS  PubMed  Google Scholar 

  4. Hölzle E, Plewig G, von Kries R, Lehmann P (1987) Polymorphous light eruption. J Invest Dermatol 88(3 Suppl):32s–38s

    Article  PubMed  Google Scholar 

  5. Norris PG, Morris J, McGibbon DM, Chu AC, Hawk JL (1989) Polymorphic light eruption: an immunopathological study of evolving lesions. Br J Dermatol 120(2):173–183

    Article  CAS  PubMed  Google Scholar 

  6. Lehmann P, Schwarz T (2011) Photodermatoses: diagnosis and treatment. Dtsch Arztebl Int 108(9):135–141

    PubMed  PubMed Central  Google Scholar 

  7. Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use. 21 CFR Parts 201 and 310. Sect. Vol. 76, No. 117 (17 June 2011)

    Google Scholar 

  8. Bech-Thomsen N, Wulf HC (1992) Sunbathers’ application of sunscreen is probably inadequate to obtain the sun protection factor assigned to the preparation. Photodermatol Photoimmunol Photomed. 9(6):242–244

    Google Scholar 

  9. Azurdia RM, Pagliaro JA, Diffey BL, Rhodes LE (1999) Sunscreen application by photosensitive patients is inadequate for protection. Br J Dermatol 140(2):255–258

    Article  CAS  PubMed  Google Scholar 

  10. Bissonnette R, Nigen S, Bolduc C (2012) Influence of the quantity of sunscreen applied on the ability to protect against ultraviolet-induced polymorphous light eruption. Photodermatol Photoimmunol Photomed 28(5):240–243

    Article  CAS  PubMed  Google Scholar 

  11. Gruber-wackernagel A, Byrne SN, Wolf P (2008) Pathogenic mechanisms of polymorphic light eruption. J Natl Cancer Inst Monogr 1:341–354

    Google Scholar 

  12. Man I, Dawe RS, Ferguson J (1999) Artificial hardening for polymorphic light eruption: practical points from ten years’ experience. Photodermatol Photoimmunol Photomed 15:96–99

    Article  CAS  PubMed  Google Scholar 

  13. Patel DC, Bellaney GJ, Seed PT, McGregor JM, Hawk JL (2000) Efficacy of short-course oral prednisolone in polymorphic light eruption: a randomized controlled trial. Br J Dermatol 143(4):828–831

    Article  CAS  PubMed  Google Scholar 

  14. Nitiyarom R, Wongpraparut C (2014) Hydroa vacciniforme and solar urticaria. Dermatol Clin 32(3):345–353, viii

    Article  CAS  PubMed  Google Scholar 

  15. Millard TP, Hawk JLM (2002) Photosensitivity disorders: cause, effect and management. Am J Clin Dermatol 3(4):239–246

    Article  PubMed  Google Scholar 

  16. Mekkes JR, de Vries HJ, Kammeyer A (2003) Solar urticaria induced by infrared radiation. Clin Exp Dermatol 28(2):222–3

    Article  CAS  PubMed  Google Scholar 

  17. Schalka S, Sant’Anna Addor FA, Agelune CM, de Melo C, Pereira V (2012) Sunscreen protection against visible light: a new proposal for evaluation. Surg Cosmet Dermatol 3(4):45–52

    Google Scholar 

  18. Sayre R, Kollias N, Roberts R (1990) Physical sunscreens. J Soc Cosmet Chem 41(2):103–109

    CAS  Google Scholar 

  19. Bissonnette R, Nigen S, Bolduc C, Méry S, Nocera T (2008) Protection afforded by sunscreens containing inorganic sunscreening agents against blue light sensitivity induced by aminolevulinic acid. Dermatol Surg 34(11):1469–1476

    CAS  PubMed  Google Scholar 

  20. Wolf R, Herzinger T, Grahovac M, Prinz JC (2013) Solar urticaria: long-term rush hardening by inhibition spectrum narrow-band UVB 311 nm. Clin Exp Dermatol 38(4):446–447

    Article  CAS  PubMed  Google Scholar 

  21. Roelandts R (1985) Pre-PUVA UVA, desensitization for solar urticaria. Photodermatol 2(3):174–176

    CAS  PubMed  Google Scholar 

  22. Masuoka E (2012) Fukunaga a, Kishigami K, et al. Successful and long-lasting treatment of solar urticaria with ultraviolet A rush hardening therapy. Br J Dermatol 167(1):198–201

    Article  CAS  PubMed  Google Scholar 

  23. Haylett AK, Nie Z, Brownrigg M, Taylor R, Rhodes LE (2011) Systemic photoprotection in solar urticaria with α-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-α-MSH. Br J Dermatol 164(2):407–414

    Article  CAS  PubMed  Google Scholar 

  24. Fusaro RM, Rice EG (2005) The maillard reaction for sunlight protection. Ann N Y Acad Sci 1043:174–183

    Article  CAS  PubMed  Google Scholar 

  25. Maksimovic L, Frémont G, Jeanmougin M, Dubertret L, Viguier M (2009) Solar urticaria successfully treated with intravenous immunoglobulins. Dermatology 218(3):252–254

    Article  PubMed  Google Scholar 

  26. Hughes R, Cusack C, Murphy GM, Kirby B (2009) Solar urticaria successfully treated with intravenous immunoglobulin. Clin Exp Dermatol 34(8):e660–e662

    Article  CAS  PubMed  Google Scholar 

  27. Collins P, Ahamat R, Green C, Ferguson J (1996) Plasma exchange therapy for solar urticaria. Br J Dermatol 134(6):1093–7

    Article  CAS  PubMed  Google Scholar 

  28. Güzelbey O, Ardelean E, Magerl M, Zuberbier T, Maurer M, Metz M (2008) Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy 63(11):1563–5

    Article  PubMed  Google Scholar 

  29. Waibel KH, Reese DA, Hamilton RG, Devillez RL (2010) Partial improvement of solar urticaria after omalizumab. J Allergy Clin Immunol 125(2):490–491

    Article  CAS  PubMed  Google Scholar 

  30. Maurer M, Rosén K, Hsieh HJ, Saini S, Grattan C, Gimenéz-Arnau A, Agarwal S, Doyle R, Canvin J, Kaplan A, Casale T (2013) Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med 368(10):924–935

    Article  CAS  PubMed  Google Scholar 

  31. Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S, Ohtsuka M, Xu ZG, Suzuki D, Tsuji K (2006) Pathogenic link between hydroa vacciniforme and Epstein-Barr virus–associated hematologic disorders. Arch Dermatol 142(5):587–95

    Article  CAS  PubMed  Google Scholar 

  32. Jacyk WK, Moosa Y (2010) Crusts and vacciniforme scars on sun-exposed skin. Clin Exp Dermatol 35(1):97–98

    Article  CAS  PubMed  Google Scholar 

  33. Halasz CL, Leach EE, Walther RR, Poh-Fitzpatrick MB (1983) Hydroa vacciniforme: induction of lesions with ultraviolet A. J Am Acad Dermatol 8(2):171–176

    Article  CAS  PubMed  Google Scholar 

  34. Sunohara A, Mizuno N, Sakai M, Kawabe Y, Sakakibara S (1988) Action spectrum for UV erythema and reproduction of the skin lesions in hydroa vacciniforme. Photodermatol 5(3):139–145

    CAS  PubMed  Google Scholar 

  35. Iwatsuki K, Ohtsuka M, Akiba H, Kaneko F (1999) Atypical hydroa vacciniforme in childhood: from a smoldering stage to Epstein-Barr virus-associated lymphoid malignancy. J Am Acad Dermatol 40(2 Pt 1):283–284

    Article  CAS  PubMed  Google Scholar 

  36. Yamamoto T, Tsuji K, Suzuki D, Morizane S, Iwatsuki K (2007) A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts. J Microbiol Methods 68(2):403–407

    Article  CAS  PubMed  Google Scholar 

  37. Huggins RH, Leithauser LA, Eide MJ, Hexsel CL, Jacobsen G, Lim HW (2009) Quality of life assessment and disease experience of patient members of a web-based hydroa vacciniforme support group. Photodermatol Photoimmunol Photomed 25(4):209–215

    Article  PubMed  Google Scholar 

  38. Gupta G, Man I, Kemmett D (2000) Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J Am Acad Dermatol 42(2 Pt 1):208–213

    Article  CAS  PubMed  Google Scholar 

  39. Almeida HL, Kopp J, Jorge VM, Sartori DS, Velloso CD (2013) Extensive hydroa vacciniforme. An Bras Dermatol 88(4):620–2

    Article  PubMed  PubMed Central  Google Scholar 

  40. Meola T, Sanchez M, Lim HW, Buchness MR, Soter NA (1997) Chronic actinic dermatitis associated with human immunodeficiency virus infection. Br J Dermatol 137(3):431–436

    Article  CAS  PubMed  Google Scholar 

  41. Kerr HA, Lim HW (2007) Photodermatoses in African Americans: a retrospective analysis of 135 patients over a 7-year period. J Am Acad Dermatol 57(4):638–643

    Article  PubMed  Google Scholar 

  42. Lim HW, Buchness MR, Ashinoff R, Soter NA (1990) Chronic actinic dermatitis. Study of the spectrum of chronic photosensitivity in 12 patients. Arch Dermatol 126(3):317–323

    Article  CAS  PubMed  Google Scholar 

  43. Russell SC, Dawe RS, Collins P, Man I, Ferguson J (1998) The photosensitivity dermatitis and actinic reticuloid syndrome (chronic actinic dermatitis) occurring in seven young atopic dermatitis patients. Br J Dermatol 138(3):496–501

    Article  CAS  PubMed  Google Scholar 

  44. Yap LM, Foley P, Crouch R, Baker C (2003) Chronic actinic dermatitis: a retrospective analysis of 44 cases referred to an Australian photobiology clinic. Australas J Dermatol 44(4):256–262

    Article  PubMed  Google Scholar 

  45. Robert S, Dawe JF (2003) Diagnosis and treatment of chronic actinic dermatitis. Dermatol Ther 16(1):45–51

    Article  Google Scholar 

  46. Moseley H, Cameron H, MacLeod T, Clark C, Dawe R, Ferguson J (2001) New sunscreens confer improved protection for photosensitive patients in the blue light region. Br J Dermatol 145(5):789–794

    Article  CAS  PubMed  Google Scholar 

  47. Dawe R, Russell SFJ (1996) Borrowing from museums and industry: two photoprotective devices. Br J Dermatol 135(6):1016–7

    Article  CAS  PubMed  Google Scholar 

  48. Paek SY, Lim HW (2014) Chronic actinic dermatitis. Dermatol Clin 32(3):355–361, viii–ix

    Article  CAS  PubMed  Google Scholar 

  49. Leigh IM, Hawk JL (1984) Treatment of chronic actinic dermatitis with azathioprine. Br J Dermatol 110(6):691–695

    Article  CAS  PubMed  Google Scholar 

  50. Murphy GM, Maurice PD, Norris PG, Morris RW, Hawk JL (1989) Azathioprine treatment in chronic actinic dermatitis: a double-blind controlled trial with monitoring of exposure to ultraviolet radiation. Br J Dermatol 121(5):639–646

    Article  CAS  PubMed  Google Scholar 

  51. Ma Y, Lu Z (2010) Treatment with topical tacrolimus favors chronic actinic dermatitis: a clinical and immunopathological study. J Dermatolog Treat 21(3):171–177

    Article  PubMed  CAS  Google Scholar 

  52. Evans AV, Palmer RA, Hawk JLM (2004) Erythrodermic chronic actinic dermatitis responding only to topical tacrolimus. Photodermatol Photoimmunol Photomed 20(1):59–61

    Article  CAS  PubMed  Google Scholar 

  53. Uetsu N, Okamoto H, Fujii K, Doi R, Horio T (2002) Treatment of chronic actinic dermatitis with tacrolimus ointment. J Am Acad Dermatol 47(6):881–884

    Article  PubMed  Google Scholar 

  54. Larangeira de Almeida H (2005) Successful treatment of chronic actinic dermatitis with topical pimecrolimus. Int J Dermatol 44(4):343–344

    Article  PubMed  Google Scholar 

  55. Thomson MA, Stewart DG, Lewis HM (2005) Chronic actinic dermatitis treated with mycophenolate mofetil. Br J Dermatol 152(4):784–786

    Article  CAS  PubMed  Google Scholar 

  56. Toonstra J, Henquet CJ, van Weelden H, van der Putte SC, van Vloten WA (1989) Actinic reticuloid. A clinical photobiologic, histopathologic, and follow-u study of 16 patients. J Am Acad Dermatol 21(2 Pt 1):205–214

    Article  CAS  PubMed  Google Scholar 

  57. Norris PG, Camp RD, Hawk JL (1989) Actinic reticuloid: response to cyclosporine. J Am Acad Dermatol 21(2 Pt 1):307–309

    Article  CAS  PubMed  Google Scholar 

  58. Wiseman MC, Orr PH, Macdonald SM, Schroeder ML, Toole JW (2001) Actinic prurigo: clinical features and HLA associations in a Canadian Inuit population. J Am Acad Dermatol 44(6):952–956

    Article  CAS  PubMed  Google Scholar 

  59. Birt AR, Davis RA (1971) Photodermatitis in North American Indians: familial actinic prurigo. Int J Dermatol 10(2):107–114

    Article  CAS  PubMed  Google Scholar 

  60. Suárez A, Valbuena MC, Rey M, de Porras Quintana L (2006) Association of HLA subtype DRB10407 in Colombian patients with actinic prurigo. Photodermatol Photoimmunol Photomed 22(2):55–58. doi:10.1111/j.1600-0781.2006.00205.x

    Article  PubMed  Google Scholar 

  61. Zuloaga-Salcedo S, Castillo-Vazquez M, Vega-Memije E et al (2007) Class I and class II major histocompatibility complex genes in Mexican patients with actinic prurigo. Br J Dermatol 156(5):1074–1075

    Article  CAS  PubMed  Google Scholar 

  62. Du P, Menage H, Vaughan RW, Baker CS et al (1996) HLA-DR4 May determine expression of actinic prurigo in British patients. J Invest Dermatol 106(2):362–364

    Article  Google Scholar 

  63. Ferguson J, Ibbotson S (1999) The idiopathic photodermatoses. Semin Cutan Med Surg 18(4):257–273

    Article  CAS  PubMed  Google Scholar 

  64. Ker KJ, Chong WS, Theng CTS (2013) Clinical characteristics of adult-onset actinic prurigo in Asians: a case series. Indian J Dermatol Venereol Leprol 79(6):783–788

    Article  PubMed  Google Scholar 

  65. Kerr AC, Ferguson J (2007) Actinic prurigo deterioration due to degradation of DermaGard window film. Br J Dermatol 157(3):619–620

    Article  CAS  PubMed  Google Scholar 

  66. Crouch R, Foley P, Baker C (2002) Actinic prurigo: a retrospective analysis of 21 cases referred to an Australian photobiology clinic. Australas J Dermatol 43(2):128–132

    Article  PubMed  Google Scholar 

  67. Daldon PE, Pascini M, Correa M (2010) Case for diagnosis. Actinic prurigo. An Bras Dermatol 85(5):733–735

    Article  PubMed  Google Scholar 

  68. Yong-Gee SA, Muir JB (2001) Long-term thalidomide for actinic prurigo. Australas J Dermatol 42(4):281–283

    Article  CAS  PubMed  Google Scholar 

  69. Trujillo MJ, de Barrio M, Rodríguez A, Moreno-Zazo M, Sánchez I, Pelta R, Tornero P, Herrero T (2001) Piroxicam-induced photodermatitis. Cross-reactivity among oxicams. A case report. Allergol Immunopathol (Madr) 29(4):133–136

    Article  CAS  Google Scholar 

  70. Ikezawa Z, Kitamura K, Osawa J, Hariya T (1992) Photosensitivity to piroxicam is induced by sensitization to thimerosal and thiosalicylate. J Invest Dermatol 98(6):918–922

    Article  CAS  PubMed  Google Scholar 

  71. Gonçalo M, Figueiredo A, Tavares P, Ribeiro CA, Teixeira F, Baptista AP (1992) Photosensitivity to piroxicam: absence of cross-reaction with tenoxicam. Contact Dermatitis 27(5):287–290

    Article  PubMed  Google Scholar 

  72. Kutlubay Z, Sevim A, Engin B, Tüzün Y (2014) Photodermatoses, including phototoxic and photoallergic reactions (internal and external). Clin Dermatol 32(1):73–79

    Article  PubMed  Google Scholar 

  73. Björn LO, Huovinen P (2002) Phototoxicity. In: Björn LO (ed) Photobiology – the science of light and life, vol 18. Kluwer Academic Publishers, Dordrecht, pp 219–238

    Google Scholar 

  74. Chantorn R, Lim HW, Shwayder TA (2012) J Am Acad Dermatol 67(6):1093.e1–e18; quiz 1111–1112

    Article  Google Scholar 

  75. Wan P, Moat S, Anstey A (2011) Pellagra: a review with emphasis on photosensitivity. Br J Dermatol 164(6):1188–1200

    Article  CAS  PubMed  Google Scholar 

  76. Charman CR, Ryan A, Tyrrell RM, Pearse AD, Arlett CF, Kurwa HA (1998) Photosensitivity associated with the Smith–Lemli–Opitz syndrome. Br J Dermatol 138(5):885–888

    Article  CAS  PubMed  Google Scholar 

  77. Anstey AV (1999) Photosensitivity in the Smith-Lemli-Opitz syndrome. Photodermatol Photoimmunol Photomed 15(6):217–218

    Article  CAS  PubMed  Google Scholar 

  78. Anstey AV, Ryan A, Rhodes LE, Charman CR, Arlett CF, Tyrrell RM, Taylor CR, Pearse AD (1999) Characterization of photosensitivity in the Smith-Lemli-Opitz syndrome : a new congenital photosensitivity syndrome. Br J Dermatol 141(3):406–415

    Article  CAS  PubMed  Google Scholar 

  79. Nwokoro NA, Mulvihill JJ (1997) Cholesterol and bile acid replacement therapy in children and adults with Smith-Lemli-Opitz (SLO/RSH) syndrome. Am J Med Genet 68(3):315–321

    Article  CAS  PubMed  Google Scholar 

  80. O’Gorman SM, Murphy GM (2014) Photoaggravated disorders. Dermatol Clin 32(3):385–398, ix

    Article  PubMed  CAS  Google Scholar 

  81. Zandman-Goddard G, Solomon M, Rosman Z, Peeva E, Shoenfeld Y (2012) Environment and lupus-related diseases. Lupus 21(3):241–250

    Article  CAS  PubMed  Google Scholar 

  82. Ashok B, Ali R (1999) Antigen binding characteristics of experimentally-induced antibodies against hydroxyl radical modified native DNA. Autoimmunity 29(1):11–19

    Article  CAS  PubMed  Google Scholar 

  83. Davis P, Russell A, Percy J (1976) Antibodies to UV light denatured DNA in systemic lupus erythematosus: detection by filter radioimmunoassay and clinical correlations. J Rheumatol 3(4):375–379

    CAS  PubMed  Google Scholar 

  84. Kuhn A, Herrmann M, Kleber S, Beckmann-Welle M, Fehsel K, Martin-Villalba A, Lehmann P, Ruzicka T, Krammer PH, Kolb-Bachofen V (2006) Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum 54(3):939–950

    Article  PubMed  Google Scholar 

  85. LeFeber WP, Norris DA, Ryan SR, Huff JC, Lee LA, Kubo M, Boyce ST, Kotzin BL, Weston WL (1984) Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. J Clin Invest 74:1545–1551

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Golan TD, Elkon KB, Gharavi AE, Krueger JG (1992) Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J Clin Invest 90(3):1067–1076

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Furukawa F, Kanauchi H, Imamura S (1994) Susceptibility to UVB light in cultured keratinocytes of cutaneous lupus erythematosus. Dermatology 189(Suppl 1):18–23

    Article  PubMed  Google Scholar 

  88. Furukawa F, Kashihara-Sawami M, Lyons M, Norris D (1990) Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol 94(1):77–85

    Article  CAS  PubMed  Google Scholar 

  89. Baron ED, Suggs AK (2014) Introduction to photobiology. Dermatol Clin 32(3):255–266, vii

    Article  CAS  PubMed  Google Scholar 

  90. Medeiros V, Lim H (2010) Sunscreens in the management of photodermatoses. Skin Therapy Lett 15(6):1–3

    CAS  PubMed  Google Scholar 

  91. Polderman MC, Huizinga TW, Le Cessie S, Pavel S (2001) UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial. Ann Rheum Dis 60(2):112–115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. McGrath H, Martínez-Osuna P, Lee FA (1996) Ultraviolet-A1 (340–400 nm) irradiation therapy in systemic lupus erythematosus. Lupus 5(4):269–274

    Article  CAS  PubMed  Google Scholar 

  93. Walchner M, Messer G, Kind P (1997) Phototesting and photoprotection in LE. Lupus 6(2):167–174

    Article  CAS  PubMed  Google Scholar 

  94. Kuhn A, Sonntag M, Richter-Hintz D et al (2001) Phototesting in lupus erythematosus: a 15-year experience. J Am Acad Dermatol 45(1):86–95

    Article  CAS  PubMed  Google Scholar 

  95. Klein LR, Elmets CA, Callen JP (1995) Photoexacerbation of cutaneous lupus erythematosus due to ultraviolet A emissions from a photocopier. Arthritis Rheum 38(8):1152–1156

    Article  CAS  PubMed  Google Scholar 

  96. Rihner M, McGrath H (1992) Fluorescent light photosensitivity in patients with systemic lupus erythematosus. Arthritis Rheum 35(8):949–952

    Article  CAS  PubMed  Google Scholar 

  97. Stege H, Budde M, Grether-Beck S, Krutmann J (2000) Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing the photoprovocation test. Photodermatol Photoimmunol Photomed 16(6):256–259

    Article  CAS  PubMed  Google Scholar 

  98. Kuhn A, Gensch K, Haust M, Meuth A, Boyer F (2010) Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus : a randomized, vehicle-controlled, double-blind study. J Am Acad Dermatol 64(1):37–48

    Article  CAS  Google Scholar 

  99. Cheong W, Hughes RV, Norris PG, Hawk JLM (1994) Cutaneous photosensitivity in dermatomyositis. Br J Dermatol 131(2):205–209

    Article  CAS  PubMed  Google Scholar 

  100. Dourmishev L, Meffert H, Piazena H (2004) Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects. Photodermatol Photoimmunol Photomed 20(5):230–234

    Article  CAS  PubMed  Google Scholar 

  101. Karalis A, Tischkowitz M, Millington GWM (2011) Dermatological manifestations of inherited cancer syndromes in children. Br J Dermatol 164(2):245–256

    Article  CAS  PubMed  Google Scholar 

  102. Fenton L, Ferguson J, Ibbotson S, Moseley H (2013) Energy-saving lamps and their impact on photosensitive and normal individuals. Br J Dermatol 169(4):910–915

    Article  CAS  PubMed  Google Scholar 

  103. Fenton L, Moseley H (2013) UV emissions from low energy artificial light sources. Photodermatol Photoimmunol Photomed 30(2–3):153–159

    Google Scholar 

  104. Fenton L, Ferguson J, Moseley H (2012) Analysis of energy saving lamps for use by photosensitive individuals. Photochem Photobiol Sci 11(8):1346–1355

    Article  CAS  PubMed  Google Scholar 

  105. Procaccini EM, Riccio G, Casula L, Posteraro G, Monfrecola G (1997) Thirty hours’ evaluation of UVB-induced erythema by chromometry and microflowmetry. Dermatology 195(4):317–320

    Article  CAS  PubMed  Google Scholar 

  106. Khazova M, O’Hagan JB (2008) Optical radiation emissions from compact fluorescent lamps. Radiat Prot Dosimetry 131(4):521–525

    Article  CAS  PubMed  Google Scholar 

  107. Tamura D, DiGiovanna JJ, Khan SG, Kraemer KH (2014) Living with xeroderma pigmentosum: comprehensive photoprotection for highly photosensitive patients. Photodermatol Photoimmunol Photomed 30(2–3):146–152

    Article  CAS  PubMed  Google Scholar 

  108. Milota M, Jones DL, Cleaver J, Jamall IS (2011) Xeroderma pigmentosum family support group: helping families and promoting clinical initiatives. DNA Repair (Amst) 10(7):792–797

    Article  CAS  Google Scholar 

  109. Webb S (2008) Xeroderma pigmentosum. BMJ 336(7641):444–446

    Article  PubMed  PubMed Central  Google Scholar 

  110. Yarosh D, Klein J, O’Connor A, Hawk J, Rafal E, Wolf P (2001) Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet 357(9260):926–929

    Article  CAS  PubMed  Google Scholar 

  111. Cainelli T, Di Padova C, Marchesi L, Gori G, Rovagnati P, Podenzani SA, Bessone E, Cantoni L (1983) Hydroxychloroquine versus phlebotomy in the treatment of porphyria cutanea tarda. Br J Dermatol 108(5):593–600

    Article  CAS  PubMed  Google Scholar 

  112. Asawanonda P, Oberlender S, Taylor C (1999) The use of dihydroxyacetone for photoprotection in variegate porphyria. Int J Dermatol 38(12):916–8

    Article  CAS  PubMed  Google Scholar 

  113. Harms J, Lautenschlager S, Minder CE, Minder EI (2009) An alpha-melanocyte-stimulating hormone analogue in erythropoietic protoporphyria. N Engl J Med 360(3):306–307

    Article  CAS  PubMed  Google Scholar 

  114. Mathews-Roth MM, Rosner B (2002) Long-term treatment of erythropoietic protoporphyria with cysteine. Photodermatol Photoimmunol Photomed 18(6):307–309

    Article  CAS  PubMed  Google Scholar 

  115. Sassa S (2006) Modern diagnosis and management of the porphyrias. Br J Haematol 135(3):281–292

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University Hospitals Case Medical Center, 11100 Euclid, Ave. Lakeside 3500, Cleveland, OH, 44106-5028, USA

    Daniel Gutierrez BS & Elma D. Baron MD

  2. School of Medicine, Case Western Reserve University, Cleveland, OH, USA

    Elma D. Baron MD

  3. Louis Stokes Department of Veterans, Affairs Medical Center, Cleveland, OH, USA

    Elma D. Baron MD

Authors
  1. Daniel Gutierrez BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elma D. Baron MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elma D. Baron MD .

Editor information

Editors and Affiliations

  1. Memorial Sloan-Kettering Cancer Cen, Dermatology Service, Basking Ridge, New Jersey, USA

    Steven Q. Wang

  2. Department of Dermatology, Henry Ford Medical Center - New Center O, Detroit, Michigan, USA

    Henry W. Lim

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Gutierrez, D., Baron, E.D. (2016). Photoprotection for Photodermatoses. In: Wang, S., Lim, H. (eds) Principles and Practice of Photoprotection. Adis, Cham. https://doi.org/10.1007/978-3-319-29382-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29382-0_3

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-29381-3

  • Online ISBN: 978-3-319-29382-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation